© 2022 MJH Life Sciences and Ophthalmology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
The multi-center, international clinical study is designed to assess the safety and efficacy of novel investigational low-dose atropin
Javascript is currently disabled in your browser. Several features of this site will not function whilst javascript is disabled.
open access to scientific and medical research
From submission to first editorial decision.
From editorial acceptance to publication.
Open
The Amsler grid is a tool that you can use at home to test your eyes for vision problems. It’s most commonly used to test for signs of age-related macular degeneration (AMD). It’s also occasionally used to test certain eye functions before cataract surgery.
This tool is named after M
On Labor Day, I always like to think about the workers who make our world function.
Some are seen — like truck drivers and first responders. Some are behind the scenes, like administrators and accountants.
Like the world of water itself, the workers behind our water are c
Featuring bladeless technology, SION is designed to facilitate a smooth, gentle goniotomy procedure
SION™ Surgical Instrument by Sight Sciences, Inc.
MENLO PARK, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused o
© 2022 MJH Life Sciences and Ophthalmology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Edward J. Holland, MD, discusses how postoperative dry eye disease after refractive and cataract procedures may lead to patient dissat
Hi, what are you looking for?
In the“Sanitary Manhole Covers”Market study, the industry landscape is covered from driving factors to upstream markets and the overall state of the market. An in-depth analysis of the overall growth prospects for the global and regional market w
Permanent link to this press release:
Delete press release Edit press rele
888-776-0942 from 8 AM - 10 PM ET
CHRIST CHURCH, Barbados , Aug. 30, 2022 /PRNewswire/ -- Evolution Optiks Limited, a privately held company specializing in light field technology, announced today that the first patients were successfully tested in a clinical study evaluating i
Permanent link to this press release:
Delete press release Edit press rele